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Background: Errorless learning (EL) is a promising rehabilitation principle for (re)learning 
instrumental activities in patients with amnesia, including patients with Korsakoff’s syndrome 
(KS). Successfully (re)learning tasks might improve the sense of competence and independence, 
and subsequently the quality of life. Quality of life in patients with KS has received limited 
attention, and no studies have been conducted to experimentally examine the effect of EL on 
quality of life in patients in this patient group.
Materials and methods: The QUALIDEM, an observation scale for quality of life, was 
completed by professional nurses before and after EL training in a group of fifty-one patients 
with KS. This scale was also completed for a group of thirty-one control patients receiving care 
as usual but no EL training.
Results: Quality of life was significantly increased on eight of the nine subscales in the Korsakoff 
group who participated in an EL training. There was a trend toward a significant increase in 
“positive affect” (ie, the ninth subscale). In contrast, no changes over time were found on any 
of the subscales in the control group that did not participate in any EL training.
Conclusion: Despite severe memory impairments, patients with KS still have the potential 
to (partially) (re)learn tasks using EL. This potential should be exploited, as the successes of 
(re)-learning might improve the quality of life of Korsakoff patients in nursing homes.
Keywords: Korsakoff’s syndrome, errorless learning, quality of life, memory
Introduction
Errorless learning (EL) is a method for teaching patients with severe memory impair-
ments everyday tasks. The occurrence of errors during learning is prevented by breaking 
down the targeted task into small steps, modeling the task steps, providing verbal 
cues, discouraging participants from guessing, correcting errors immediately, fading 
cues carefully, and rehearsing retrieved information.1,2 The efficacy of EL has been 
established in patients with dementia and acquired brain injury.1,2 The findings from 
the few studies that have used EL principles in patients with Korsakoff’s syndrome 
(KS) are mostly positive.3–5
KS is an irreversible, neuropsychiatric disorder resulting from thiamine deficiency 
and depletion following years of chronic alcohol abuse. It is characterized by dispro-
portionate learning and memory impairments, relative to other features of cognitive 
functioning.6–8 Generally, executive dysfunctions are also present.9 The severe memory 
impairments and executive dysfunctions in patients with KS have serious effects on daily 
life functioning. Tasks once learned might be forgotten, and the ability to learn new tasks 
is compromised. Successfully (re)learning tasks might improve the sense of competence 
and independence, and subsequently the quality of life. This was, for example, dem-
onstrated by Cohen et al.10 They explored the effects of EL in a woman with profound 
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memory and executive function impairments associated with 
three distinct etiologies (ie, developmental disability, surgical 
removal of a large portion of limbic tissue, and traumatic brain 
injury). Cohen et al10 described that the increasing functional 
competence and independence significantly improved the 
quality of life in this patient. In contrast, another study11 did 
not find significant changes on self-reported quality of life (on 
the RAND 36-item Short Form Health Survey [RAND-36]) 
after adding an EL component to goal management training, 
compared with conventional goal management training in 
brain-injured patients with executive deficits. They concluded 
that the improvement of specific daily activities did not affect 
the patients’ well-being.11 The RAND-36 was completed by 
the participant directly after training. For future studies, the 
authors recommended longer follow-up assessments and the 
inclusion of an untrained control group.
Quality of life in patients with KS has received limited 
attention. So far, only Oudman and Zwart12 have pioneered 
this field of study. Oudman and Zwart12 compared the scores 
on a quality-of-life observation scale (QUALIDEM)13,14 in 
patients with dementia or KS. The scores of the QUALIDEM 
subscales were linearly transformed from 0 to 100, with 
higher scores indicating a higher quality of life. Oudman and 
Zwart12 reported that the general quality of life was higher 
in patients with KS compared with patients with dementia. 
However, the mean quality-of-life score in the Korsakoff 
group could be considered moderate (M = 66.8, SD = 13.4). 
The lowest scores were found on the subscales “care relation-
ship” (M = 55.2, SD = 21.9) and “having something to do” 
(M = 55.1, SD = 33.8). Subsequently, Oudman and Wijnia15 
performed a 20-month follow-up study on quality of life in 
the same sample of patients with KS. They concluded that 
quality of life remains relatively stable over time in this 
patient group. Statistically significant, yet relatively small, 
improvements were only found on the subscales “positive 
affect,” “care relationship,” and “feeling at home.” It is 
unclear whether variables such as cognitive functioning are 
associated with quality of life in this patient group.
So far, no studies have been conducted to experimentally 
examine the effect of EL on different aspects of quality of 
life in patients with KS. Specifically, (re)learning activities 
with the help of a professional carer can be hypothesized to 
improve “care relationship” and “having something to do,” 
that is, the aspects of quality of life that received the lowest 
scores in patients with KS in the Oudman and Zwart study.12 
The aim of the current study was to examine the quality of 
life in a group of Korsakoff patients who were trained with 
EL technique, and in a patient-control group who received 
care as usual. Following the suggestion by Bertens et al,11 we 
included an untrained control group and included a longer 
follow-up assessment period. Moreover, it is important to 
unravel the underlying factor(s) that contribute to quality of 
life in patients with KS. Therefore, we examined the relation 
between quality of life and cognitive functioning over time.
Methods
Participants
Eighty-three patients with KS participated in this study. Fifty-
two patients completed the EL training and thirty-one served as 
controls, receiving care as usual, but no EL training. In short, 
patients who received EL training were trained in two instru-
mental tasks of daily living (eg, making coffee and brushing 
teeth, using an agenda). The training was completed when no 
improvement was observed after 3 consecutive training ses-
sions. Professional caregivers rated the performance of the tasks 
before and after training on a 5-point rating scale (1 = unable 
to execute the task, 5 = executes task with ease). The results 
showed a significant improvement in the execution of tasks after 
the EL intervention. Improvements were found for different 
types of tasks (ie, activities of daily living, chores, mobility, 
housekeeping). The patient-control group who received care as 
usual did not engage in any EL training, but otherwise received 
the same care, as the institutions were highly comparable.
To be included in the present study, patients had to 
meet the criteria for Diagnostic and Statistical Manual of 
Diseases-5 alcohol-induced major neurocognitive disorder.16 
In addition, the criteria for alcoholic KS had to be met, 
including having a disproportionate memory and a history of 
malnutrition or thiamine deficit.7 Patients older than 70 with 
declining Montreal Cognitive Assessment17 (MoCA) scores 
over time were excluded from this study because of possible 
dementia. Another exclusion criterion was the presence of 
acute psychiatric conditions, such as psychosis or major 
depression. Patients in the EL group were recruited from the 
nursing homes MeanderGroep (Kerkrade, the Netherlands) 
and ZorgAccent (Hellendoorn, the Netherlands). The 
control group was recruited from the nursing home Atlant 
(Beekbergen, the Netherlands). The institutions cooperate 
in a Dutch network for innovative Korsakoff care. Prior to 
the study, all patients and their legal representatives gave 
their written informed consent. This study was approved 
by the ethical committee of Atlant nursing home and the 
institutional review boards of all participating institutions 
(Atlant, Meander Groep, and ZorgAccent).
The quality of life follow-up observations (T2) were 
obtained approximately 14 months after baseline observations 
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(T1) and 5 months after completion of the training in the EL 
group, with the aim to have long follow-up assessment 
periods. For the control group, the follow-up observations 
were obtained eleven months after baseline observation.
Outcome measures
The QUALIDEM was administered as a measure of quality of 
life.13,14 It is an observation scale developed for patients with 
dementia in nursing homes and contains 37 questions that can 
be divided into nine subscales, and three additional questions 
are for further research. The subscales need to be assessed 
individually and are not suitable for calculating a total score. 
The subscales are: Caregiver relationship, positive affect, 
negative affect, restless behavior, positive self-image, social 
relations, social isolation, feeling at home, and having some-
thing to do. Caregivers rated answers on a 4-point Likert scale. 
For each category, a higher score means a better quality of life. 
Two professional carers (including the first responsible care-
giver of the patient) completed the QUALIDEM together so as 
to control for the mixed interrater reliability of the subscales 
(varying from Cronbach’s α 0.49 for positive self-image to 
Cronbach’s α 0.79 for care relation). The QUALIDEM was 
completed after an observation period of one week. Following 
Oudman and Zwart12 and Oudman and Wijnia,15 the score on 
each subscale was linearly transformed from 0 to 100, with 
higher scores reflecting a better quality of life.
The MoCA17 was administered and scored by a psy-
chologist to assess global cognitive functioning. The stan-
dard version (7.1) was administered at baseline (T1) and the 
7.2 version was administered at follow-up (T2). The MoCA 
total scores were used in the current study.
Thirty professional carers from the experimental institu-
tions and eleven professional carers from the control insti-
tution were asked to complete a self-report questionnaire 
on their professional experience to identify and rule out 
important differences between the carers who completed 
the QUALIDEM. The questionnaire was completed before 
the start of the experiment, so both groups of carers did not 
receive any information about EL from the authors. However, 
the caregivers knew whether they were assigned to the experi-
mental or control institution. This self-report questionnaire 
contained questions about the number of years of experience 
in health care, and more specifically, in the care for patients 
with KS. It also contained questions about their expertise 
(eg, “how familiar are you with the symptoms of the KS”), 
openness to trying new methods (eg, “how important is it for 
you to implement new methods in your work?”), and expec-
tations of the effectiveness of EL (eg, “Do you expect that 
EL improves the quality of life of the patients?”). Caregivers 
rated answers on a 7-point scale.
analyses
Nonparametric statistical analyses were performed, as the 
normality assumption was violated for most subscales. 
Mann–Whitney-U-tests were used to compare the groups 
baseline performance on the QUALIDEM subscales. 
Wilcoxon signed-rank tests were performed to examine 
 QUALIDEM subscale scores over time (T1 and T2) in the 
EL group and the control group.
The QUALIDEM and MoCA were administered at 
baseline (T1) and at the end (T2) of the study. The difference 
scores were calculated by subtracting the scores obtained at the 
start from the scores obtained at the end (T2 - T1). Spearman 
rank correlation coefficients (two-tailed) were computed 
between the QUALIDEM difference subscale scores and 
MoCA difference score in the EL group and the control group, 
as most difference scores were not normally distributed.
Results
Demographics
One patient in the EL group was excluded because of 
possible dementia. The EL group consisted of 51 patients 
(38 men; mean age = 59.9, range 46–73 years). The control 
group consisted of 31 patients (22 men; mean age = 62.2, 
range 49–74 years), who received care as usual. Table 1 
summarizes the group characteristics. The groups did not 
differ significantly with respect to age, sex distribution, time 
in nursing home, MoCA total score, or educational level. 
Educational level was measured in accordance with the Dutch 
educational system using a 7-point rating scale, ranging from 
1 is (less than primary education) to 7 (university degree). 
Both groups had median scores of 4 (range =1–6).
Table 1 characteristics of the el group and the control group
Characteristics EL group
(n=51)
Control group
(n=31)
p-value
age (years) 59.9 (6.3) 62.2 (8.1) ns
sex (male/female) 38/13 22/9 ns
education (level) 4 (1–6) 4 (1–6) ns
Time in nursing home 
(years)
6.8 (5.9) 7.9 (6.6) ns
Moca total score 16.1 (4.7) 15.1 (3.5) ns
Notes: Mean and standard deviations are presented for age, time in nursing 
home, and Moca total score, frequency scores are given for the variable ‘sex’, and 
median and range are presented for education. educational code, the level of formal 
education, was assessed using seven categories based on a Dutch classification 
system using a 7-point rating scale, ranging from 1 to (less than primary education) 
to 7 (university degree). ns results (p.0.05) were obtained.
Abbreviations: el, errorless learning; Moca, Montreal cognitive assessment, 
version 7.1; ns, nonsignificant.
 
N
eu
ro
ps
yc
hi
at
ric
 D
ise
as
e 
an
d 
Tr
ea
tm
en
t d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
13
1.
17
4.
24
8.
14
9 
on
 0
6-
De
c-
20
17
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Neuropsychiatric Disease and Treatment 2017:13submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
2870
rensen et al
Table 2 summarizes the group characteristics of the pro-
fessional carers from the experimental and control institution. 
Significant differences between the groups of caregivers 
who completed the QUALIDEM for the patients were only 
found on the question: “Do you expect that errorless learn-
ing improves the quality of life of the patients?” (Z = -2.2, 
p = 0.049). The caregivers from the experimental institution 
had higher expectations of the effects of EL on quality of life 
than the caregivers from the control institution.
Baseline QUaliDeM scores
Mean scores and standard deviations on the QUALIDEM 
subscales for the EL group and the control group at baseline 
are presented in Table 3. The EL group and the control group 
only differed significantly at baseline on the subscale “restless 
behavior” (U = 464.0, Z = -3.1, p = 0.002), with the EL group 
showing more restless behavior than the controls. The two 
groups did not differ significantly on the other subscales.
QUaliDeM scores over time
Mean scores and standard deviations on the QUALIDEM 
subscales at T1 and T2 for the EL group and the control 
group are presented in Table 3. Wilcoxon signed-rank 
tests showed that scores on the subscales “caregiver rela-
tion” (Z = -2.78, p = 0.005), “negative affect” (Z = -2.30, 
p = 0.022), “restless behavior” (Z = -2.55, p = 0.011), 
“positive self-image” (Z = -2.76, p = 0.006), “social rela-
tions” (Z = -3.27, p = 0.001), “social isolation” (Z = -3.20, 
p = 0.001), “feeling at home” (Z = -2.05, p = 0.040), and 
“having something to do” (Z = -2.72, p = 0.007) improved 
significantly over time in the EL group. A marginally signifi-
cant increase over time was found for the subscale “positive 
affect” in this group (Z = -1.87, p = 0.062).
In the control group, a significant difference was only 
found on the subscale “restless behavior” (Z =  -2.14, 
p = 0.033). Interestingly, restless behavior increased over 
time in this group. No significant differences between 
T1 and T2 were found for the other subscales of the 
QUALIDEM in the control group.
Quality of life and cognitive functioning
None of the QUALIDEM difference subscale scores cor-
related significantly with the MoCA difference score in the 
EL group or the control group (all p $ 0.137).
Discussion
The aim of this study was to examine the effect of EL 
on quality of life in patients with KS. Quality of life was 
significantly increased on eight of the nine subscales on 
a quality-of-life observation scale in the Korsakoff group 
patients who participated in EL training. There was a trend 
toward a significant increase in “positive affect” (ie, the ninth 
Table 2 characteristics of the caregivers who rated patients 
with Ks in the el group and the control group
Group demographics EL group
(n=30)
Control group
(n=11)
p-value
Years of experience in 
health care
20.5 (9.9) 19.8 (9.2) ns
Years of experience with Ks 12.0 (8.2) 11.5 (7.0) ns
Familiar with causes of Ksa 6.2 (0.7) 6.6 (0.5) ns
Familiar with symptoms of Ksa 6.1 (0.6) 6.4 (0.5) ns
it is important to implement 
new methodsa
6.1 (1.0) 6.2 (1.0) ns
el improves quality of lifea 6.4 (0.7) 5.8 (0.9) 0.049
Notes: Data shown as mean (standard deviation). ascale ranging from 1–7, with 
higher scores indicating more years of experience, familiarity, importance, and more 
positive expectations. ns results (p.0.05) were obtained.
Abbreviations: el, errorless learning; Ks, Korsakoff’s syndrome; ns, non-
significant.
Table 3 Observed quality of life scores in a group of patients with Ks trained with el (el group) and a group of patients with Ks 
receiving care as usual (control group)
QUALIDEM subscalesa EL group (n=51) p-value Control group (n=31) p-value
Baseline After 14 months Basline After 11 months
care relationship 46.7 (16.4) 52.5 (16.0) 0.005* 47.7 (14.4) 45.2 (18.6) 0.359
Positive affect 58.6 (15.4) 62.8 (13.8) 0.062 56.1 (16.9) 57.7 (17.8) 0.474
Negative affect 54.4 (18.4) 59.6 (15.9) 0.022* 53.8 (21.4) 53.5 (17.2) 0.664
restless, tense behavior 34.3 (21.3) 42.0 (21.9) 0.011* 49.5 (18.2) 40.9 (21.0) 0.033*
Positive self-image 57.7 (17.8) 66.3 (12.9) 0.006* 62.9 (15.2) 62.4 (15.2) 0.842
social relations 46.9 (14.4) 54.7 (13.7) 0.001* 44.5 (16.9) 47.0 (17.4) 0.258
social isolation 50.0 (16.0) 58.8 (14.0) 0.001* 55.9 (16.1) 50.8 (20.1) 0.106
Feeling at home 52.1 (18.7) 58.2 (19.8) 0.040* 57.9 (15.5) 61.3 (19.5) 0.109
having something to do 43.9 (23.5) 52.9 (24.2) 0.007* 42.7 (21.1) 43.5 (23.9) 0.792
Notes: Data shown as mean (standard deviation). aQUaliDeM means scale scores range: 0–100, higher scores indicate better quality of life. *p,0.05.
Abbreviations: el, errorless learning; Ks, Korsakoff’s syndrome.
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subscale). In contrast, no changes over time were found on 
any of the subscales in the control group that did not partici-
pate in EL training. The results in the control group are in line 
with a previous study examining quality of life in patients 
with KS, showing that quality of life remains relatively stable 
in this patient group.15 Although the average quality of life is 
rated higher in patients with KS than, for example, in patients 
with other forms of dementia,12 their quality of life can be 
considered “moderate” at best. The subscales “care relation-
ship” and “having something to do” were rated particularly 
low by professional carers in a previous study.10 The results 
of the current study showed that (re)learning everyday tasks 
might significantly improve most aspects of quality of life in 
patients with KS, including “care relationship” and “having 
something to do.”
Patients with KS have impaired explicit memory and 
relatively spared implicit memory processes.18–20 EL training 
has been suggested to be a particularly useful method for 
patients with amnesia because it does not require error 
detection and monitoring, that is, memory functions.1 So far, 
only a few studies have examined and demonstrated the 
efficacy of EL as a method for (re)learning tasks in patients 
with KS.3–5 Subsequently, it has been suggested that success-
fully (re)learning tasks might improve a patients’ sense of 
competence and independence, and subsequently improve 
their quality of life. Our study is the first to provide empirical 
evidence for this hypothesis in patients with KS. The fact that 
the follow-up data was gathered 5 months after completion 
of the training in the EL group offers further support for the 
impact of the intervention, showing that the improvements 
in quality of life are maintained up to 5 months after the 
training has been completed.
We did not observe any significant correlations between 
cognitive functioning and different aspects of quality of 
life over time. This is in line with studies in (Alzheimer’s) 
dementia, which consistently found no associations between 
cognitive function (as measured with the Mini-Mental State 
Examination)21 and quality of life in patients with moderate 
to severe dementia.23–25 Factors that negatively affect quality 
of life in dementia include awareness of memory impair-
ments, depressed mood, severity of irritability, quality of 
relationship (rated by the patient with dementia), and male 
gender.22,24,25 Future studies should focus further on detecting 
predictors of quality of life in patients with KS.
This is the first study to systematically examine the 
effect of EL on quality of life in a relatively large and 
homogeneous sample of patients with KS. Nevertheless, 
some limitations of this study have to be acknowledged. 
First, the caregivers who completed the observation scales 
were not blinded to the conditions. Moreover, almost no 
differences were found between the groups of caregivers 
from the experimental and control institution who completed 
the QUALIDEM, except for their expectations of the effect 
of EL training on quality of life. Both groups of caregivers 
expected positive results of EL on quality of life in patients 
with KS, but the caregivers from the experimental institution 
even more so than the caregivers from the control institution. 
Although the self-report questionnaires were completed 
before any of the caregivers received any information on 
EL from the experimenters, the caregivers knew whether 
they were assigned to the experimental or control institution, 
which might have affected the results. It would be valu-
able for future studies to include blinded raters and match 
the groups of raters on outcome expectations. Second, we 
asked caregivers to rate the quality of life of patients with 
KS, not the patients themselves. We deliberately did not 
include self-report questionnaires, as patients with KS lack 
insight into oneself and one’s disease, resulting in invalid 
responses.26,27 From a research perspective, however, to be 
able to further substantiate the validity of the quality of 
life reports, it may still be relevant to include self-reported 
quality of life, next to observed quality of life. Third, the 
QUALIDEM has been developed for assessing quality of 
life in patients with dementia. However, quality of life for 
patients with dementia might differ from that in patients with 
KS. Recently, an observation scale for assessing quality of 
life in patients with Korsakoff’s has been developed: the 
QUALIKO.28 This includes aspects which are not covered 
in the QUALIDEM, but are important for the quality of 
life in patients with Korsakoff’s, according to specialized 
Korsakoff caregivers. Two subscales that have been added 
to the QUALIKO are “autonomy” and “productivity.” The 
QUALIKO was not used in this study because the rest–
retest reliability of the instrument has not been examined 
and norms are lacking. Future studies on quality of life in 
patients with KS should, however, also focus on autonomy 
and productivity in this patient group. Last, unfortunately, 
information on the duration of alcohol misuse and time since 
abstinence was missing. In patients with KS, some recov-
ery of alcohol-related brain damage and cognitive deficits 
has been observed after weeks, months, or even years of 
abstinence.29–31 Moreover, longer duration and severity of 
the period of alcohol dependence might result in more severe 
cognitive deficits. It is unclear what the implications of these 
factors are for the effects of EL. It has been suggested that 
more severely impaired patients might benefit more from 
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EL principles.32 Future studies should include information 
on the duration and severity of alcohol use and also use an 
abstinence period of at least 6 weeks before testing.31
Conclusion
Our study is the first to examine the effects of participating 
in an EL training on quality of life in patients with KS. 
Despite severe memory impairments, patients with KS still 
have the potential to (partially) (re)learn tasks using EL. This 
potential should be exploited, as the successes of (re)learning 
might improve the quality of life of Korsakoff patients in 
nursing homes.
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